15-Apr-2025 6:00 AM CST - Business Wire 908 Devices Announces Preliminary First Quarter 2025 Financial Results 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for safety and defense tech applications, today announced preliminary unaudited financial results for the quarter ended March 31, 2025. Preliminary unaudited revenue from continuing operations for the first quarter of 2025 is expected to be at least $11.5 million, compared to $7.4 million of revenue from continuing operations in the first quarter of
4-Mar-2025 6:45 AM CST - Business Wire 908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter and full year ended December 31, 2024. Strategic Transformation Realized 908 Devices cements its unique position as a market-leading provider of analytical tools for tackling critical public health and safety crises through the divestiture of its bioprocessing desktop assets to Repligen Corporation. This transac
4-Mar-2025 6:30 AM CST - Business Wire Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc. (Nasdaq: MASS), a pioneer in purpose-built handheld and desktop devices for chemical analysis, announce that Repligen has purchased 908 Devices desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications. 908 Devices remains focused on the growth of its newly expanded handheld device
3-Mar-2025 4:00 PM CST - Business Wire 908 Devices to Participate in Upcoming Investor Conferences 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced it will participate in the following investor conferences. TD Cowen 45th Annual Healthcare Conference, Boston, MA Fireside chat on Wednesday, March 5 at 9:50 a.m. Eastern Time Leerink Global Healthcare Conference, Miami, FL Fireside chat on Tuesday, March 11 at 1 p.m. Eastern Time Interested parties may access a live and archived webcast of the
3-Mar-2025 3:30 PM CST - Business Wire 908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical analysis, today announced it will report financial results for the fourth quarter and full year 2024 before market open on Tuesday, March 4, 2025. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Live audio of the webcast will be available on the Investors section of the company website at: www.908devices.
14-Jan-2025 3:01 PM CST - Business Wire 908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced preliminary unaudited financial results for the quarter and full year ended December 31, 2024. Preliminary unaudited revenue for the fourth quarter of 2024 is expected to be approximately $17.2 million, compared to $14.4 million in the fourth quarter of 2023, reflecting reported growth of approximately 20%. Fourth quarter handheld revenues grew
12-Nov-2024 6:00 AM CST - Business Wire 908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter ended September 30, 2024. While we are pleased that our revenue increased year-over-year due to our newly acquired products, our third quarter results fell short of our expectations due to challenges from the delayed FY24 federal budget, delays with advancing international contracts, and ongoing softness in the
4-Nov-2024 6:00 AM CST - Business Wire 908 Devices to Participate in Upcoming Investor Conferences 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced it will participate in the following investor conferences. Stifel Healthcare Conference, New York, NY Fireside chat on Tuesday, November 19 at 8:35 a.m. Eastern Time 26th Annual Stephens Investment Conference, Nashville, TN Fireside chat on Wednesday, November 20 at 3 p.m. Central Time / 4 p.m. Eastern Time Interested parties may access a live
22-Oct-2024 6:00 AM CST - Business Wire 908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024 908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical analysis, today announced it will report financial results for the third quarter 2024 before market open on Tuesday, November 12, 2024. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Live audio of the webcast will be available on the Investors section of the company website at: www.908devices.com. The we
15-Apr-2025 6:00 AM CST - Business Wire 908 Devices Announces Preliminary First Quarter 2025 Financial Results 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for safety and defense tech applications, today announced preliminary unaudited financial results for the quarter ended March 31, 2025. Preliminary unaudited revenue from continuing operations for the first quarter of 2025 is expected to be at least $11.5 million, compared to $7.4 million of revenue from continuing operations in the first quarter of
4-Mar-2025 6:45 AM CST - Business Wire 908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter and full year ended December 31, 2024. Strategic Transformation Realized 908 Devices cements its unique position as a market-leading provider of analytical tools for tackling critical public health and safety crises through the divestiture of its bioprocessing desktop assets to Repligen Corporation. This transac
4-Mar-2025 6:30 AM CST - Business Wire Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc. (Nasdaq: MASS), a pioneer in purpose-built handheld and desktop devices for chemical analysis, announce that Repligen has purchased 908 Devices desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications. 908 Devices remains focused on the growth of its newly expanded handheld device
3-Mar-2025 4:00 PM CST - Business Wire 908 Devices to Participate in Upcoming Investor Conferences 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced it will participate in the following investor conferences. TD Cowen 45th Annual Healthcare Conference, Boston, MA Fireside chat on Wednesday, March 5 at 9:50 a.m. Eastern Time Leerink Global Healthcare Conference, Miami, FL Fireside chat on Tuesday, March 11 at 1 p.m. Eastern Time Interested parties may access a live and archived webcast of the
3-Mar-2025 3:30 PM CST - Business Wire 908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical analysis, today announced it will report financial results for the fourth quarter and full year 2024 before market open on Tuesday, March 4, 2025. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Live audio of the webcast will be available on the Investors section of the company website at: www.908devices.
14-Jan-2025 3:01 PM CST - Business Wire 908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced preliminary unaudited financial results for the quarter and full year ended December 31, 2024. Preliminary unaudited revenue for the fourth quarter of 2024 is expected to be approximately $17.2 million, compared to $14.4 million in the fourth quarter of 2023, reflecting reported growth of approximately 20%. Fourth quarter handheld revenues grew
12-Nov-2024 6:00 AM CST - Business Wire 908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter ended September 30, 2024. While we are pleased that our revenue increased year-over-year due to our newly acquired products, our third quarter results fell short of our expectations due to challenges from the delayed FY24 federal budget, delays with advancing international contracts, and ongoing softness in the
4-Nov-2024 6:00 AM CST - Business Wire 908 Devices to Participate in Upcoming Investor Conferences 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced it will participate in the following investor conferences. Stifel Healthcare Conference, New York, NY Fireside chat on Tuesday, November 19 at 8:35 a.m. Eastern Time 26th Annual Stephens Investment Conference, Nashville, TN Fireside chat on Wednesday, November 20 at 3 p.m. Central Time / 4 p.m. Eastern Time Interested parties may access a live
22-Oct-2024 6:00 AM CST - Business Wire 908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024 908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical analysis, today announced it will report financial results for the third quarter 2024 before market open on Tuesday, November 12, 2024. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Live audio of the webcast will be available on the Investors section of the company website at: www.908devices.com. The we
